Sample size calculation
The total trial size will be 2660 patients, 1330 randomised
to Aspirin group and 1330 randomised to Placebo
group. In the sub-groups, there should be at least 2000
high risk Dukes B or Dukes C colon cancer patients,
others are rectal cancer patients